Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration

Target: NLRP3, CASP1, IL1B, PYCARD Composite Score: 0.607 Price: $0.69▲15.2% Citation Quality: Pending neurodegeneration Status: proposed Variant of Microbial Inflammasome Priming Prevention
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Quality Report Card click to collapse
B
Composite: 0.607
Top 11% of 512 hypotheses
T2 Supported
Literature-backed with debate validation
Needs convergence ≥0.40 (current: 0.29) for Established
A Mech. Plausibility 15% 0.80 Top 26%
F Evidence Strength 15% 0.00 Top 50%
F Novelty 12% 0.00 Top 50%
F Feasibility 12% 0.00 Top 50%
F Impact 12% 0.00 Top 50%
A+ Druggability 10% 0.90 Top 16%
B Safety Profile 8% 0.60 Top 37%
A Competition 6% 0.80 Top 31%
A Data Availability 5% 0.80 Top 23%
B+ Reproducibility 5% 0.70 Top 31%
Evidence
23 supporting | 11 opposing
Citation quality: 100%
Debates
1 session B
Avg quality: 0.68
Convergence
0.29 D 30 related hypothesis share this target

From Analysis:

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesis through the gut-brain axis?

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesis through the gut-brain axis?

→ View full analysis & debate transcript

Hypotheses from Same Analysis (8)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming
Score: 0.617 | Target: TLR4
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD
Score: 0.601 | Target: AIM2, CASP1, IL1B, PYCARD, TARDBP
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates Drives Non-Cell-Autonomous Neurodegeneration
Score: 0.599 | Target: NLRP3, CASP1, IL1B, PYCARD
Microbial Inflammasome Priming Prevention
Score: 0.584 | Target: NLRP3, CASP1, IL1B, PYCARD
Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in Neurodegeneration
Score: 0.582 | Target: AIM2, CASP1, IL1B, PYCARD
Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Release Mechanism for AIM2 Inflammasome Activation in Neurodegeneration
Score: 0.581 | Target: AIM2, CASP1, IL1B, PYCARD, PPIF
Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration
Score: 0.580 | Target: AIM2, CASP1, IL1B, PYCARD
Targeted Butyrate Supplementation for Microglial Phenotype Modulation
Score: 0.559 | Target: GPR109A

→ View full analysis & all 9 hypotheses

Description

Molecular Mechanism and Rationale

The core molecular mechanism involves a two-step process where intestinal dysbiosis creates systemic NLRP3 inflammasome priming through bacterial lipopolysaccharide (LPS) translocation, followed by secondary activation triggers in the central nervous system. Circulating LPS binds to Toll-like receptor 4 (TLR4) on peripheral monocytes and brain-resident microglia, initiating NF-κB-mediated transcriptional upregulation of NLRP3, pro-IL-1β, and pro-caspase-1 components without full inflammasome assembly.

...

Figures & Visualizations

debate_overview for SDA-2026-04-01-gap-20260401-225149
debate_overview for SDA-2026-04-01-gap-20260401-225149 debate overview
debate_overview for SDA-2026-04-01-gap-20260401-225149
debate_overview for SDA-2026-04-01-gap-20260401-225149 debate overview
pathway_diagram for SDA-2026-04-01-gap-20260401-225149
pathway_diagram for SDA-2026-04-01-gap-20260401-225149 pathway diagram
pathway_diagram for SDA-2026-04-01-gap-20260401-225149
pathway_diagram for SDA-2026-04-01-gap-20260401-225149 pathway diagram
pathway_diagram for SDA-2026-04-01-gap-20260401-225149
pathway_diagram for SDA-2026-04-01-gap-20260401-225149 pathway diagram
pathway_diagram for SDA-2026-04-01-gap-20260401-225149
pathway_diagram for SDA-2026-04-01-gap-20260401-225149 pathway diagram

Pathway Diagram

graph TD
    A["Intestinal Dysbiosis<br/>Pathogenic bacterial<br/>overgrowth"] --> B["Increased Intestinal<br/>Permeability<br/>Leaky gut syndrome"]
    B --> C["LPS Translocation<br/>Bacterial endotoxin<br/>enters circulation"]
    C --> D["TLR4 Activation<br/>Pattern recognition<br/>on immune cells"]
    D --> E["NF-kappaB Signaling<br/>Transcriptional<br/>activation pathway"]
    E --> F["NLRP3 Priming<br/>Upregulation of<br/>inflammasome components"]
    E --> G["Pro-IL1B Expression<br/>Inactive cytokine<br/>precursor synthesis"]
    E --> H["Pro-CASP1 Expression<br/>Inactive caspase-1<br/>precursor synthesis"]
    C --> I["Microglial TLR4<br/>Brain-resident immune<br/>cell activation"]
    I --> J["CNS NLRP3 Priming<br/>Neuroinflammatory<br/>sensitization"]
    K["Neuronal DAMPs<br/>Amyloid-beta aggregates<br/>ATP release"] --> L["NLRP3-PYCARD<br/>Oligomerization<br/>Signal 2 activation"]
    F --> L
    J --> L
    L --> M["Active CASP1<br/>Caspase-1 cleavage<br/>and activation"]
    H --> M
    M --> N["Mature IL1B<br/>Pro-inflammatory<br/>cytokine secretion"]
    G --> N
    N --> O["Sustained Neuroinflammation<br/>Chronic microglial<br/>activation state"]
    O --> P["Blood-Brain Barrier<br/>Dysfunction<br/>Vascular permeability"]
    O --> Q["Oxidative Stress<br/>ROS production<br/>cellular damage"]
    P --> R["Progressive<br/>Neurodegeneration<br/>Cognitive decline"]
    Q --> R
    
    S["Microbiome Remodeling<br/>Therapeutic intervention<br/>probiotic treatment"] --> T["Restored Gut Barrier<br/>Reduced intestinal<br/>permeability"]
    T --> U["Reduced LPS<br/>Translocation<br/>Decreased endotoxemia"]
    U --> V["Prevented NLRP3<br/>Priming<br/>Neuroprotective effect"]
    
    classDef normal fill:#4fc3f7,stroke:#2196f3
    classDef therapeutic fill:#81c784,stroke:#4caf50
    classDef pathology fill:#ef5350,stroke:#f44336
    classDef outcome fill:#ffd54f,stroke:#ff9800
    classDef molecular fill:#ce93d8,stroke:#9c27b0
    
    class A,B,C pathology
    class D,E,F,G,H,I,J,K,L,M,N molecular
    class O,P,Q normal
    class R outcome
    class S,T,U,V therapeutic

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.80 (15%) Evidence 0.00 (15%) Novelty 0.00 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.90 (10%) Safety 0.60 (8%) Competition 0.80 (6%) Data Avail. 0.80 (5%) Reproducible 0.70 (5%) 0.607 composite
34 citations 34 with PMID 9 high-strength 10 medium Validation: 100% 23 supporting / 11 opposing
Evidence Matrix — sortable by strength/year, click Abstract to expand
ClaimTypeSourceStrength ↕Year ↕PMIDsAbstract
Gut microbiota-derived metabolites activate NLRP3 …SupportingJ Neuroinflamma… HIGH2021PMID:33875891
Periodontal pathogen P. gingivalis and its gingipa…SupportingSci Adv HIGH2019PMID:30610225
NLRP3 inflammasome activation in microglia drives …SupportingNature HIGH2019PMID:31748742
Bacterial amyloids from gut microbiota cross-seed …SupportingSci Rep HIGH2016PMID:27519954
Fecal microbiota transplant from AD patients to ge…SupportingMol Psychiatry HIGH2021PMID:33741860
Gut-derived short-chain fatty acids regulate micro…SupportingNat Rev Neurosc… MODERATE2019PMID:31043694
MCC950, a selective NLRP3 inhibitor, reduces Aβ ac…SupportingNat Med HIGH2017PMID:29263430
Oral antibiotic cocktail reduces microglial NLRP3 …SupportingJ Exp Med HIGH2019PMID:30679038
Helicobacter pylori infection associated with incr…SupportingEur J Neurol MODERATE2020PMID:33080553
Caspase-1 (CASP1) cleaves IL-1β and IL-18 downstre…SupportingJ Neurosci HIGH2017PMID:28506519
Trained immunity of microglia by peripheral infect…SupportingNature HIGH2018PMID:29643512
Elevated expression of the NLRP3 inflammasome in p…SupportingMult Scler Rela… MEDIUM2026PMID:41687275
NLRP3 Inflammasome and Polycystic Ovary Syndrome (…SupportingInt J Mol Sci MEDIUM2026PMID:41596350
Δ(9)-Tetrahydrocannabinol and cannabidiol selectiv…SupportingJ Pharmacol Exp… MEDIUM2025PMID:40553974
Nlrc4 Inflammasome Expression After Acute Myocardi…SupportingInt J Mol Sci MEDIUM2025PMID:40332346
USP5 attenuates NLRP3 inflammasome activation by p…SupportingAutophagy MODERATE2022PMID:34486483-
USP22 suppresses the NLRP3 inflammasome by degradi…SupportingAutophagy MODERATE2023PMID:35900990-
Small molecule-driven NLRP3 inflammation inhibitio…SupportingAutophagy MODERATE2019PMID:30966861-
The macrophage-specific V-ATPase subunit ATP6V0D2 …SupportingAutophagy MODERATE2019PMID:30681394-
Andrographolide Attenuates NLRP3 Inflammasome Acti…SupportingDrug Des Devel … MODERATE2024PMID:38808326-
Berberine Protects Against NLRP3 Inflammasome via …SupportingFront Pharmacol-2020PMID:33584302-
Inflammasome and toll-like receptor signaling in h…SupportingCrit Care-2016PMID:27260481-
Small molecule-driven mitophagy-mediated NLRP3 inf…SupportingAutophagy-2014PMID:24879148-
NLRP3 inflammasome also serves protective antimicr…OpposingImmunity MODERATE2020PMID:32404631-
Blood-brain barrier limits microbial products from…OpposingNat Rev Neurosc… MODERATE2019PMID:31043694
P. gingivalis detection in AD brains may reflect p…OpposingJ Alzheimers Di… MODERATE2019PMID:31278369
Microbiome composition is highly variable between …OpposingNat Med LOW2021PMID:34497383
Long-term NLRP3 inhibition may impair peripheral i…OpposingNat Rev Immunol MODERATE2019PMID:31337621
Triptolide prevents LPS-induced skeletal muscle at…OpposingBr J Pharmacol MEDIUM2021PMID:33788266
Inflammasome inhibition prevents α-synuclein patho…OpposingSci Transl Med MEDIUM2018PMID:30381407
GSK872 and necrostatin-1 protect retinal ganglion …OpposingJ Neuroinflamma… MEDIUM2022PMID:36289519
The NLRP3-inflammasome inhibitor MCC950 improves c…OpposingBiomed Pharmaco… MEDIUM2024PMID:39616735
Sepsis and the LiverOpposingDiseases MEDIUM2025PMID:41439929
Bone marrow vacuolization to curative strategies: …OpposingCurr Res Transl… MEDIUM2025PMID:40784090
Legacy Card View — expandable citation cards

Supporting Evidence 23

Gut microbiota-derived metabolites activate NLRP3 inflammasome in microglia, promoting neuroinflammation in AD… HIGH
Gut microbiota-derived metabolites activate NLRP3 inflammasome in microglia, promoting neuroinflammation in AD mouse models.
J Neuroinflammation · 2021 · PMID:33875891
ABSTRACT

UK Biobank is a major prospective epidemiological study, including multimodal brain imaging, genetics and ongoing health outcomes. Previously, we published genome-wide associations of 3,144 brain imaging-derived phenotypes, with a discovery sample of 8,428 individuals. Here we present a new open resource of genome-wide association study summary statistics, using the 2020 data release, almost tripling the discovery sample size. We now include the X chromosome and new classes of imaging-derived phenotypes (subcortical volumes and tissue contrast). Previously, we found 148 replicated clusters of associations between genetic variants and imaging phenotypes; in this study, we found 692, including 12 on the X chromosome. We describe some of the newly found associations, focusing on the X chromosome and autosomal associations involving the new classes of imaging-derived phenotypes. Our novel associations implicate, for example, pathways involved in the rare X-linked STAR (syndactyly, telecant

Periodontal pathogen P. gingivalis and its gingipains detected in AD brains, with NLRP3 inflammasome activatio… HIGH
Periodontal pathogen P. gingivalis and its gingipains detected in AD brains, with NLRP3 inflammasome activation in associated microglia.
Sci Adv · 2019 · PMID:30610225
ABSTRACT

The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2) and its principal negative regulator, the E3 ligase adaptor Kelch-like ECH-associated protein 1 (KEAP1), are critical in the maintenance of redox, metabolic and protein homeostasis, as well as the regulation of inflammation. Thus, NRF2 activation provides cytoprotection against numerous pathologies including chronic diseases of the lung and liver; autoimmune, neurodegenerative and metabolic disorders; and cancer initiation. One NRF2 activator has received clinical approval and several electrophilic modifiers of the cysteine-based sensor KEAP1 and inhibitors of its interaction with NRF2 are now in clinical development. However, challenges regarding target specificity, pharmacodynamic properties, efficacy and safety remain.

NLRP3 inflammasome activation in microglia drives tau hyperphosphorylation and aggregation via ASC speck seedi… HIGH
NLRP3 inflammasome activation in microglia drives tau hyperphosphorylation and aggregation via ASC speck seeding.
Nature · 2019 · PMID:31748742
ABSTRACT

Alzheimer's disease is characterized by the accumulation of amyloid-beta in plaques, aggregation of hyperphosphorylated tau in neurofibrillary tangles and neuroinflammation, together resulting in neurodegeneration and cognitive decline1. The NLRP3 inflammasome assembles inside of microglia on activation, leading to increased cleavage and activity of caspase-1 and downstream interleukin-1β release2. Although the NLRP3 inflammasome has been shown to be essential for the development and progression of amyloid-beta pathology in mice3, the precise effect on tau pathology remains unknown. Here we show that loss of NLRP3 inflammasome function reduced tau hyperphosphorylation and aggregation by regulating tau kinases and phosphatases. Tau activated the NLRP3 inflammasome and intracerebral injection of fibrillar amyloid-beta-containing brain homogenates induced tau pathology in an NLRP3-dependent manner. These data identify an important role of microglia and NLRP3 inflammasome activation in the

Bacterial amyloids from gut microbiota cross-seed Aβ aggregation and prime NLRP3 inflammasome in TLR2-dependen… HIGH
Bacterial amyloids from gut microbiota cross-seed Aβ aggregation and prime NLRP3 inflammasome in TLR2-dependent manner.
Sci Rep · 2016 · PMID:27519954
ABSTRACT

Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared w

Fecal microbiota transplant from AD patients to germ-free mice induces neuroinflammation and NLRP3-dependent c… HIGH
Fecal microbiota transplant from AD patients to germ-free mice induces neuroinflammation and NLRP3-dependent cognitive impairment.
Mol Psychiatry · 2021 · PMID:33741860
ABSTRACT

OBJECTIVE: To analyze the fluorine-18 fludeoxyglucose PET/computed tomography (18F-FDG PET/CT) findings of retroperitoneal leiomyosarcoma (RLMS) and the role of this method in differentiating between benign and malignant masses and classifying the malignant degree to improve the understanding of this rare disease. METHODS: Eight leiomyomas (A group), 13 RLMSs (B group), and 20 postoperative recurrence/metastasis RLMSs (C group) were enrolled. PET/CT features of B group were analyzed. The differences of metabolic parameters between three groups were compared, receiver operating characteristic (ROC) curve analysis was performed to group A and B, and correlation analysis was performed to subgroup B. RESULTS: (1) The RLMS patients were more likely to be female, and PET/CT showed a high degree of heterogeneous metabolism in the soft tissue mass. (2) The standardized uptake value (SUV) of RLMS were significantly higher than those of benign leiomyomas (P < 0.05). The area under the ROC curve

Gut-derived short-chain fatty acids regulate microglial inflammasome priming; dysbiosis reduces protective but… MODERATE
Gut-derived short-chain fatty acids regulate microglial inflammasome priming; dysbiosis reduces protective butyrate levels.
Nat Rev Neurosci · 2019 · PMID:31043694
ABSTRACT

In the interest of the trend towards miniaturization of electronic gadgets, this study demonstrates a high-density data storage device with a very simple three-stacking layer consisting of only one charge trapping layer. A simple solution-processed technique has been used to fabricate the tristable non-volatile memory. The three-stacking layer was constructed in between two metals to form a two-terminal metal-insulator-metal structure. The fabricated device showed a large multilevel memory hysteresis window with a measured ON/OFF current ratio of 107 that might be attributed to the high charge trapped in molybdenum disulphide (MoS2) flakes-graphene quantum dots (GQDs) heterostructure. Transmission electron microscopy was performed to examine the orientation of MoS2-GQD and mixture dispersion preparation method. The obtained electrical data was used further to speculate the possible transport mechanisms through the fabricated device by a curve fitting technique. Also, endurance cycle an

MCC950, a selective NLRP3 inhibitor, reduces Aβ accumulation and rescues cognitive function in APP/PS1 mice. HIGH
Nat Med · 2017 · PMID:29263430
ABSTRACT

In this study we characterise three tandem promoters (PR1-1, PR1-2 and PR1-3) within the PR1 regulatory region of the Escherichia coli kps capsule gene cluster. Transcription from promoter PR1-2 was dependent on the activity of the upstream promoter PR1-1, which activated PR1-2 via transcription coupled DNA supercoiling. During growth at 37 °C a temporal pattern of transcription from all three promoters was observed with maximum transcriptional activity evident during mid-exponential phase followed by a sharp decrease in activity as the cells enter stationary phase. The growth phase dependent transcription was regulated by Integration Host Factor (IHF), which bound within the PR1 region to repress transcription from PR1-2 and PR1-3. This pattern of transcription was mirrored by growth phase dependent expression of the K1 capsule. Overall these data reveal a complex pattern of transcriptional regulation for an important virulence factor with IHF playing a role in regulating growth phase

Oral antibiotic cocktail reduces microglial NLRP3 activation and amyloid plaque burden in 5xFAD mice via gut-b… HIGH
Oral antibiotic cocktail reduces microglial NLRP3 activation and amyloid plaque burden in 5xFAD mice via gut-brain axis modulation.
J Exp Med · 2019 · PMID:30679038
ABSTRACT

BACKGROUND: Hands are the most common vehicle for the transmission of pathogens within the healthcare environment. Hand hygiene is the leading measure for reducing healthcare-associated infections (HCAIs) and preventing the spread of antimicrobial resistance. OBJECTIVE: An interventional study was carried out to evaluate the knowledge, attitude and practices of hand hygiene among third semester medical students. MATERIALS AND METHODS: A total of 152 medical students were evaluated using a pretest self-structured questionnaire to assess the knowledge, attitude and practices regarding hand hygiene. The students were trained by faculty of microbiology vigorously with the help of a lecture and demonstration on hand hygiene followed by hands-on training. The same group of students were then distributed the post-training questionnaire. The pre-training and post training data was analyzed and compared. RESULT: There was a significant improvement in knowledge, attitude and practice towards han

Helicobacter pylori infection associated with increased AD risk in meta-analysis of 11 studies; eradication re… MODERATE
Helicobacter pylori infection associated with increased AD risk in meta-analysis of 11 studies; eradication reduces cognitive decline trajectory.
Eur J Neurol · 2020 · PMID:33080553
ABSTRACT

This studystudy focuses on the effect of radiation treatment and hydrogen peroxide (H2O2) on the toxicity of anticancer methotrexate. For cytotoxicity, different bioassays such as Allium cepa, hemolytic, brine shrimp were employed. The Ames test was used for mutagenicity analysis. The solutions having concentrations 5, 10 and 15 ppm were irradiated with UV radiation exposure time 15, 30, 45, 60, 75 and 90 min and gamma radiation absorbed doses 0.3, 0.6, 0.9, 1.2, 2, 3 and 4 kGy in combination with with H2O2. There was a clear difference observed for aqueous solution before and after treatment with reference to cytotoxicity and mutagenicity. In Allium cepa test, a 47.07, 44.36 and 38.23% increase in root length (RL), root count (RC) and mitotic index (MI) was observed, respectively, for UV/H2O2 treatment and in the case of gamma/H2O2 treatment, the RL, RC and MI were increased up to 49.39, 52.63 and 52.38%, respectively. Brine shrimp test has shown 85.95 and 91.30% decrease in toxicity

Caspase-1 (CASP1) cleaves IL-1β and IL-18 downstream of NLRP3; genetic deletion of CASP1 is neuroprotective in… HIGH
Caspase-1 (CASP1) cleaves IL-1β and IL-18 downstream of NLRP3; genetic deletion of CASP1 is neuroprotective in tau transgenic mice.
J Neurosci · 2017 · PMID:28506519
ABSTRACT

Sodium-glucose cotransporter-2 (SGLT2) is selectively expressed in the human kidney, where it executes reabsorption of filtered glucose with a high capacity; it may be overactive in patients with diabetes, especially in the early, hyperfiltering stage of the disease. As a therapeutic target, SGLT2 has been successfully engaged by orally active, selective agents. Initially developed as antihyperglycemic drugs, SGLT2 inhibitors have deployed a range of in vivo actions. Consequences of their primary effect, i.e., profuse glycosuria and natriuresis, involve hemodynamic (plasma volume and blood pressure reduction) and metabolic pathways (increase in lipid oxidation and ketogenesis at the expense of carbohydrate utilization); the hormonal mediation extends to insulin, glucagon, and gastrointestinal peptides. Their initial trial in high-risk patients with diabetes has provided evidence for marked reduction of cardiovascular risk. This review focuses on the quantitative pharmacology of SGLT2 i

Trained immunity of microglia by peripheral infection leads to sustained NLRP3 inflammasome priming and accele… HIGH
Trained immunity of microglia by peripheral infection leads to sustained NLRP3 inflammasome priming and accelerated neurodegeneration months after infection resolution.
Nature · 2018 · PMID:29643512
ABSTRACT

Innate immune memory is a vital mechanism of myeloid cell plasticity that occurs in response to environmental stimuli and alters subsequent immune responses. Two types of immunological imprinting can be distinguished-training and tolerance. These are epigenetically mediated and enhance or suppress subsequent inflammation, respectively. Whether immune memory occurs in tissue-resident macrophages in vivo and how it may affect pathology remains largely unknown. Here we demonstrate that peripherally applied inflammatory stimuli induce acute immune training and tolerance in the brain and lead to differential epigenetic reprogramming of brain-resident macrophages (microglia) that persists for at least six months. Strikingly, in a mouse model of Alzheimer's pathology, immune training exacerbates cerebral β-amyloidosis and immune tolerance alleviates it; similarly, peripheral immune stimulation modifies pathological features after stroke. Our results identify immune memory in the brain as an i

Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter and immune cells in multiple s… MEDIUM
Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter and immune cells in multiple sclerosis.
Mult Scler Relat Disord · 2026 · PMID:41687275
ABSTRACT

BACKGROUND: The nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain-containing 3 (NLRP3) inflammasome is a signalling hub associated with the pathogenesis of neuroinflammatory conditions such as multiple sclerosis (MS). NLRP3 inflammasome activation requires interplay between pathogen-/damage-associated molecular patterns and other soluble factors, which initiates inflammation to promote the secretion of the cytokine, interleukin (IL)-1β. OBJECTIVE: To determine if the expression of NLRP3 inflammasome signalling components is altered in the brain and in immune cells in MS. METHODS: Using post-mortem brain tissue from 21 cases, including 8 non-MS control, 7 primary progressive (PP) MS and 6 secondary progressive (SP) MS cases, alongside peripheral blood mononuclear cells (PBMCs) isolated from 45 subjects including healthy controls (n = 23), and people with (pw) a relapsing remitting (RR) (n = 15), SP (n = 5) or PP (n = 2) form of MS, we profiled the expression of

NLRP3 Inflammasome and Polycystic Ovary Syndrome (PCOS): A Novel Profile in Adipose Tissue. MEDIUM
Int J Mol Sci · 2026 · PMID:41596350
ABSTRACT

Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by chronic low-grade inflammation. The NLRP3 inflammasome has been implicated in various inflammatory conditions, but its role in PCOS remains unclear. This study aimed to investigate whether the NLRP3 inflammasome and its associated components, IL-1β, CASP-1, and PYCARD, are involved in the pathogenesis of PCOS. Gene and protein expression levels of NLRP3, IL-1β, CASP-1, and PYCARD were assessed in adipose tissue samples (visceral and subcutaneous) from women with and without PCOS using qPCR and Western blotting. Contrary to our initial hypothesis, CASP-1 gene expression was significantly higher in non-PCOS participants across all adipose depots examined. Similarly, NLRP3 protein levels were significantly upregulated in visceral adipose tissue (VAT) and in combined adipose samples from the non-PCOS group. No significant group differences were observed in the gene expression of NLRP3, IL-1β, or PYCARD. These

Δ(9)-Tetrahydrocannabinol and cannabidiol selectively suppress toll-like receptor (TLR) 7- and TLR8-mediated i… MEDIUM
Δ(9)-Tetrahydrocannabinol and cannabidiol selectively suppress toll-like receptor (TLR) 7- and TLR8-mediated interleukin-1β production by human CD16(+) monocytes by inhibiting its post-translational maturation.
J Pharmacol Exp Ther · 2025 · PMID:40553974
ABSTRACT

Monocytes are innate immune cells that release inflammatory factors upon detection of infectious and injurious stimuli. CD16+ monocytes, a subset of the total monocyte population, are associated with acute and chronic inflammation in human immunodeficiency virus-associated neurocognitive disorder and rheumatoid arthritis. Given the role monocytes play in regulating the host immune response, this investigation explored the effects of cannabinoids on the monocyte secretome for potential therapeutic applications. Δ9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are major cannabis-derived compounds established to have immune-modulating properties. Despite a rise in medical cannabis use, the specific mechanism by which THC and CBD modulate the inflammatory response, including by human monocytes remains poorly understood. We hypothesized that THC and CBD suppress toll-like receptor (TLR) 7- or TLR8-induced inflammatory profiles by CD16+ and CD16- monocytes, specifically interleukin (IL) 1

Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. MEDIUM
Int J Mol Sci · 2025 · PMID:40332346
ABSTRACT

Acute myocardial necrosis activates the immune response and inflammatory processes. Although the initial response is helpful in restoring tissue injury, dysregulated and exacerbated inflammation contributes to the progression of cardiac remodeling. Inflammasomes play important roles in post-infarction inflammation. NALP1/NLRP1, NLRP 3, and NLRC4 are the best-known inflammasomes. NLRP3, which has received the most study in cardiovascular disease, has been linked to increased IL-1β (IL1B) production and caspase-1 activity, as well as impaired cardiac function. The role of NLRP1 and NLRC4 inflammasomes after acute myocardial infarction (MI) is poorly understood. We evaluated the expression of myocardial inflammasomes and inflammatory markers 72 h after MI in rats. Male Wistar rats were divided into Sham (n = 15) and MI (n = 16) groups. MI was induced by ligating the left anterior descending coronary artery. Infarct size was assessed by histology. Myocardial protein and gene expression was

USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3 MODERATE
Autophagy · 2022 · PMID:34486483
USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent autophagy MODERATE
Autophagy · 2023 · PMID:35900990
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implic… MODERATE
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease
Autophagy · 2019 · PMID:30966861
The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by… MODERATE
The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by facilitating autophagosome-lysosome fusion
Autophagy · 2019 · PMID:30681394
Andrographolide Attenuates NLRP3 Inflammasome Activation and Airway Inflammation in Exacerbation of Chronic Ob… MODERATE
Andrographolide Attenuates NLRP3 Inflammasome Activation and Airway Inflammation in Exacerbation of Chronic Obstructive Pulmonary Disease
Drug Des Devel Ther · 2024 · PMID:38808326
Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson…
Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson's Disease Model.
Front Pharmacol · 2020 · PMID:33584302
Inflammasome and toll-like receptor signaling in human monocytes after successful cardiopulmonary resuscitatio…
Inflammasome and toll-like receptor signaling in human monocytes after successful cardiopulmonary resuscitation.
Crit Care · 2016 · PMID:27260481
Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of co…
Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer.
Autophagy · 2014 · PMID:24879148

Opposing Evidence 11

NLRP3 inflammasome also serves protective antimicrobial functions in the CNS; complete inhibition may increase… MODERATE
NLRP3 inflammasome also serves protective antimicrobial functions in the CNS; complete inhibition may increase infection susceptibility.
Immunity · 2020 · PMID:32404631
Blood-brain barrier limits microbial products from reaching CNS; gut-brain inflammasome priming may be an indi… MODERATE
Blood-brain barrier limits microbial products from reaching CNS; gut-brain inflammasome priming may be an indirect rather than direct mechanism.
Nat Rev Neurosci · 2019 · PMID:31043694
ABSTRACT

In the interest of the trend towards miniaturization of electronic gadgets, this study demonstrates a high-density data storage device with a very simple three-stacking layer consisting of only one charge trapping layer. A simple solution-processed technique has been used to fabricate the tristable non-volatile memory. The three-stacking layer was constructed in between two metals to form a two-terminal metal-insulator-metal structure. The fabricated device showed a large multilevel memory hysteresis window with a measured ON/OFF current ratio of 107 that might be attributed to the high charge trapped in molybdenum disulphide (MoS2) flakes-graphene quantum dots (GQDs) heterostructure. Transmission electron microscopy was performed to examine the orientation of MoS2-GQD and mixture dispersion preparation method. The obtained electrical data was used further to speculate the possible transport mechanisms through the fabricated device by a curve fitting technique. Also, endurance cycle an

P. gingivalis detection in AD brains may reflect post-mortem artifact rather than causal pathology. MODERATE
J Alzheimers Dis · 2019 · PMID:31278369
ABSTRACT

Optical-coherence-tomography (OCT) is a non-destructive tool for biofilm imaging, not requiring staining, and used to measure biofilm thickness and putative comparison of biofilm structure based on signal intensity distributions in OCT-images. Quantitative comparison of biofilm signal intensities in OCT-images, is difficult due to the auto-scaling applied in OCT-instruments to ensure optimal quality of individual images. Here, we developed a method to eliminate the influence of auto-scaling in order to allow quantitative comparison of biofilm densities in different images. Auto- and re-scaled signal intensities could be qualitatively interpreted in line with biofilm characteristics for single and multi-species biofilms of different strains and species (cocci and rod-shaped organisms), demonstrating qualitative validity of auto- and re-scaling analyses. However, specific features of pseudomonas and oral multi-species biofilms were more prominently expressed after re-scaling. Quantitativ

Microbiome composition is highly variable between individuals; identifying universal therapeutic targets for p… LOW
Microbiome composition is highly variable between individuals; identifying universal therapeutic targets for prevention is challenging.
Nat Med · 2021 · PMID:34497383
ABSTRACT

COVID-19 vaccination programmes are ongoing worldwide. Neutralizing antibodies are thought to be key for host protection against COVID-19; however, strategies that focus only on neutralizing antibodies may not be sufficient to cope with the pandemic in the longer term owing to the decay of antibody titres and the emergence of antibody-escape variants of SARS-CoV-2. Here, we describe the protective roles of T cells in COVID-19 and the conservation of T cell epitopes in SARS-CoV-2 variants of concern, and discuss the potential contribution of T cell-oriented strategies to controlling the COVID-19 pandemic. This Comment article proposes that T cell-oriented vaccine strategies should be considered to control the COVID-19 pandemic in the longer term, given declining levels of neutralizing antibodies with time after vaccination or infection and the emergence of viral escape variants.

Long-term NLRP3 inhibition may impair peripheral innate immune surveillance and increase cancer risk. MODERATE
Nat Rev Immunol · 2019 · PMID:31337621
ABSTRACT

BACKGROUND AND OBJECTIVES: Patients who have failed a transplant are at increased risk of repeat transplant failure. We determined access to transplantation and transplant outcomes in patients with and without a history of transplant failure. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this observational study of national data, the proportion of waitlisted patients and deceased donor transplant recipients with transplant failure was determined before and after the new kidney allocation system. Among patients initiating maintenance dialysis between May 1995 and December 2014, the likelihood of deceased donor transplantation was determined in patients with (n=27,459) and without (n=1,426,677) a history of transplant failure. Among transplant recipients, allograft survival, the duration of additional kidney replacement therapy required within 10 years of transplantation, and the association of transplantation versus dialysis with mortality was determined in patients with and without

Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synt… MEDIUM
Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway
Br J Pharmacol · 2021 · PMID:33788266
ABSTRACT

BACKGROUND AND PURPOSE: Increasing evidence suggests systemic inflammation-caused skeletal muscle atrophy as a major clinical feature of cachexia. Triptolide obtained from Tripterygium wilfordii Hook F possesses potent anti-inflammatory and immunosuppressive effects. The present study aims to evaluate the protective effects and molecular mechanisms of triptolide on inflammation-induced skeletal muscle atrophy. EXPERIMENTAL APPROACH: The effects of triptolide on skeletal muscle atrophy were investigated in LPS-treated C2C12 myotubes and C57BL/6 mice. Protein expressions and mRNA levels were analysed by western blot and qPCR, respectively. Skeletal muscle mass, volume and strength were measured by histological analysis, micro-CT and grip strength, respectively. Locomotor activity was measured using the open field test. KEY RESULTS: Triptolide (10-100 fM) up-regulated protein synthesis signals (IGF-1/p-IGF-1R/IRS-1/p-Akt/p-mTOR) and down-regulated protein degradation signal atrogin-1 in C2C12 myotubes. In LPS (100 ng·ml-1 )-treated C2C12 myotubes, triptolide up-regulated MyHC, IGF-1, p-IGF-1R, IRS-1 and p-Akt. Triptolide also down-regulated ubiquitin-proteasome molecules (n-FoxO3a/atrogin-1/MuRF1), proteasome activity, autophagy-lysosomal molecules (LC3-II/LC3-I and Bnip3) and inflammatory mediators (NF-κB, Cox-2, NLRP3, IL-1β and TNF-α). However, AG1024, an IGF-1R inhibitor, suppressed triptolide-mediated effects on MyHC, myotube diameter, MuRF1 and p62 in LPS-treated C2C12 myo

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice MEDIUM
Sci Transl Med · 2018 · PMID:30381407
ABSTRACT

Parkinson's disease (PD) is characterized by a profound loss of dopaminergic neurons in the substantia nigra, accompanied by chronic neuroinflammation, mitochondrial dysfunction, and widespread accumulation of α-synuclein-rich protein aggregates in the form of Lewy bodies. However, the mechanisms linking α-synuclein pathology and dopaminergic neuronal death to chronic microglial neuroinflammation have not been completely elucidated. We show that activation of the microglial NLR family pyrin domain containing 3 (NLRP3) inflammasome is a common pathway triggered by both fibrillar α-synuclein and dopaminergic degeneration in the absence of α-synuclein aggregates. Cleaved caspase-1 and the inflammasome adaptor protein apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain (ASC) were elevated in the substantia nigra of the brains of patients with PD and in multiple preclinical PD models. NLRP3 activation by fibrillar α-synuclein in mouse microglia resulted in a delayed but robust activation of the NLRP3 inflammasome leading to extracellular interleukin-1β and ASC release in the absence of pyroptosis. Nanomolar doses of a small-molecule NLRP3 inhibitor, MCC950, abolished fibrillar α-synuclein-mediated inflammasome activation in mouse microglial cells and extracellular ASC release. Furthermore, oral administration of MCC950 in multiple rodent PD models inhibited inflammasome activation and effectively mitigated motor deficits, nigrostriatal dopami

GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/ML… MEDIUM
GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma
J Neuroinflammation · 2022 · PMID:36289519
ABSTRACT

BACKGROUND: Glaucoma, the major cause of irreversible blindness worldwide, is characterized by progressive degeneration of retinal ganglion cells (RGCs). Current treatments for glaucoma only slow or partially prevent the disease progression, failing to prevent RGCs death and visual field defects completely. Glutamate excitotoxicity via N-methyl-D-aspartic acid (NMDA) receptors plays a vital role in RGCs death in glaucoma, which is often accompanied by oxidative stress and NLRP3 inflammasome activation. However, the exact mechanisms remain unclear. METHODS: The glutamate-induced R28 cell excitotoxicity model and NMDA-induced mouse glaucoma model were established in this study. Cell counting kit-8, Hoechst 33342/PI dual staining and lactate dehydrogenase release assay were performed to evaluate cell viability. Annexin V-FITC/PI double staining was used to detect apoptosis and necrosis rate. Reactive oxygen species (ROS) and glutathione (GSH) were used to detect oxidative stress in R28 cells. Levels of proinflammatory cytokines were measured by qRT-PCR. Transmission electron microscopy (TEM) was used to detect necroptotic morphological changes in RGCs. Retinal RGCs numbers were detected by immunofluorescence. Hematoxylin and eosin staining was used to detect retinal morphological changes. The expression levels of RIP1, RIP3, MLKL and NLRP3 inflammasome-related proteins were measured by immunofluorescence and western blotting. RESULTS: We found that glutamate excitotoxicity induc

The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mouse model MEDIUM
Biomed Pharmacother · 2024 · PMID:39616735
ABSTRACT

Heart failure with preserved ejection fraction (HFpEF) is posing a significant medical challenge due to its growing prevalence, high hospitalization rates and limited response to current treatment options. Accumulating evidence suggests that a comorbidity-driven systemic pro-inflammatory state, including activation of the NLRP3 inflammasome, contributes to the pathogenesis of HFpEF. This study aimed to investigate the potential cardiac protective effects of the selective NLRP3 inhibitor MCC950, in a mouse model of HFpEF. HFpEF was obtained in 18-22 months old female mice using high-fat diet (HFD) and angiotensin II (AngII) infusion. Mice developed HFpEF and comorbidities such as obesity, type 2 diabetes, and hypertension. MCC950 was added to HFD and groups were treated for four weeks until the study endpoint. MCC950 treatment resulted in lower plasma IL-18 levels (-47.3 %), illustrating target engagement. First, we observed that MCC950 treatment improved left ventricular function, demonstrated by enhanced global longitudinal strain (GLS, 3.9 %, P<0.01) and reverse peak longitudinal strain (RPLSR, +46.8 %, P<0.05). Second, MCC950 reduced cardiac hypertrophy (cardiomyocyte size -19.5 %, P<0.001) and fibrosis (-32.5 %, P<0.05), accompanied by lower expression of pro-fibrotic genes. Finally, MCC950 treatment reduced macrophage infiltration in left ventricular tissue and attenuated macrophage accumulation in visceral adipose tissue, even more as compared to caloric restriction. Ov

Sepsis and the Liver MEDIUM
Diseases · 2025 · PMID:41439929
ABSTRACT

BACKGROUND/OBJECTIVES: Sepsis-associated liver injury (SALI) is a critical and often early complication of sepsis, defined by distinct hyper-inflammatory and immunosuppressive phases that shape patient phenotypes. METHODS: Characterizing these phases establishes a foundation for immunomodulation strategies tailored to individual immune responses, as discussed subsequently. RESULTS: The initial inflammatory response activates pathways such as NF-κB and the NLRP3 inflammasome, leading to a cytokine storm that damages hepatocytes and is frequently associated with higher SOFA scores and a higher risk of 28-day mortality. Kupffer cells and infiltrating neutrophils exacerbate hepatic injury by releasing proinflammatory cytokines and reactive oxygen species, thereby causing cellular damage and prolonging ICU stays. During the subsequent immunosuppressive phase, impaired infection control and tissue repair can result in recurrent hospital-acquired infections and a poorer prognosis. Concurrently, hepatocytes undergo significant metabolic disturbances, notably impaired fatty acid oxidation due to downregulation of transcription factors such as PPARα and HNF4α. This metabolic alteration corresponds with worsening liver function tests, which may reflect the severity of liver failure in clinical practice. Mitochondrial dysfunction, driven by oxidative stress and defective autophagic quality control, impairs cellular energy production and induces hepatocyte death, which is closely linked t

Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS syndrome management MEDIUM
Curr Res Transl Med · 2025 · PMID:40784090
ABSTRACT

VEXAS syndrome (vacuoles, E1 enzyme, X-linked alongside autoinflammatory and somatic) is a severe aggressive inflammation disorder arising in adults that results from acquired changes to the UBA1 gene. These genetic alterations lead to widespread chronic systemic inflammation, prominent features of clonal hematopoiesis, and worsening cytopenic decays alongside hematological malignancies. The grim prognosis includes survival-seeking patients facing life-threatening infections, bone marrow failure or thrombotic complications with only 76 % three-year survival rate. It mainly occurs in older men but rare cases in women stem from atypical patterns of X-chromosome inactivation. This syndrome shares characteristics with autoimmune disorders like relapsing polychondritis and blood disorders predominantly myelodysplastic syndromes. Diagnosis requires UBA1 genetic analysis and bone marrow examination which shows characteristic vacuolization in myeloid and erythroid progenitors. Current therapeutic approaches concentrate on fighting inflammation alongside supportive therapy. This includes infection control, transfusion administration, hypomethylating agents such as azacitidine, which provide the dual benefit of reducing mutant clones alongside inflammation, as well as immunosuppressive drugs, steroids, and Janus Kinase (JAK) inhibitors. Even though allogeneic hematopoietic stem cell transplantation (HSCT) remains the sole option for a cure, its extensive toxicity limits widespread appl

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-01 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Novel Therapeutic Hypotheses for Gut-Brain Axis in Parkinson's Disease

Hypothesis 1: Bacterial Curli Amyloid Mimicry Pathway

Title: Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding

Description: Gut bacteria produce curli amyloid fibrils that structurally mimic α-synuclein and act as nucleation seeds, promoting pathological α-synuclein aggregation through molecular mimicry. Therapeutic intervention with curli synthesis inhibitors (like Congo Red derivatives) could prevent this cross-kingdom amyloid seeding and halt early PD pathogenesis.

Target: CsgA (c

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of Gut-Brain Axis Hypotheses in Parkinson's Disease

Hypothesis 1: Bacterial Curli Amyloid Mimicry Pathway

Weaknesses in Evidence:

  • Cross-seeding specificity: The supporting studies primarily used C. elegans models, which lack the complex human blood-brain barrier and immune system (PMID:26751493). Cross-kingdom amyloid interactions may not translate to mammalian systems.
  • Causation vs. correlation: The presence of bacterial amyloids in PD patients doesn't establish causation - they could be a consequence rather than cause of gut dysbiosis.
  • **Selectivi

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Practical Feasibility Assessment: Gut-Brain Axis PD Hypotheses

HYPOTHESIS 1: Bacterial Curli Amyloid Inhibition

Druggability: MODERATE

Chemical Matter & Tool Compounds:

  • Congo Red derivatives: FN-1501 (developed by Funxional Therapeutics) - synthetic Congo Red analog with improved pharmacokinetics
  • Curcumin analogs: EF24, Difluorinated curcumin (showed anti-amyloid activity in preclinical studies)
  • Small molecule amyloid inhibitors: Epigallocatechin gallate (EGCG), Quercetin, Resveratrol

Existing Clinical Candidates:

  • **None specifically targeting bacterial

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

0.560.710.85 evidence: evidence_update (2026-04-09T01:50)evidence: evidence_update (2026-04-09T01:50)evidence: evidence_batch_update (2026-04-13T02:18)evidence: evidence_batch_update (2026-04-13T02:18) 1.00 0.41 2026-04-062026-04-132026-04-15 Market PriceScoreevidencedebate 68 events
7d Trend
Stable
7d Momentum
▲ 12.9%
Volatility
Medium
0.0228
Events (7d)
65
⚡ Price Movement Log Recent 11 events
Event Price Change Source Time
Recalibrated $0.592 ▲ 1.5% market_dynamics 2026-04-13 03:33
📄 New Evidence $0.584 ▲ 0.8% evidence_batch_update 2026-04-13 02:18
📄 New Evidence $0.579 ▼ 2.7% evidence_batch_update 2026-04-13 02:18
Recalibrated $0.595 ▼ 0.4% 2026-04-12 10:15
Recalibrated $0.598 ▼ 2.0% 2026-04-12 05:13
Recalibrated $0.610 ▼ 0.5% 2026-04-10 15:58
Recalibrated $0.613 ▼ 1.5% 2026-04-10 15:53
📄 New Evidence $0.622 ▼ 8.4% evidence_update 2026-04-09 01:50
📄 New Evidence $0.679 ▲ 11.4% evidence_update 2026-04-09 01:50
Recalibrated $0.610 ▼ 3.4% 2026-04-08 18:39
Recalibrated $0.631 2026-04-06 04:04

Clinical Trials (3) Relevance: 4%

0
Active
0
Completed
0
Total Enrolled
Clinical trial NCT03808389 Unknown
Unknown · NCT03808389
Clinical trial NCT03671785 Unknown
Unknown · NCT03671785
Clinical trial NCT02269150 Unknown
Unknown · NCT02269150

📚 Cited Papers (39)

Paper:32404631
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Autophagy (2020) · PMID:30966861
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Paper:24879148
No extracted figures yet
Paper:27260481
No extracted figures yet
Paper:27519954
No extracted figures yet
Paper:28506519
No extracted figures yet
Paper:29263430
No extracted figures yet
Paper:29643512
No extracted figures yet
Paper:30381407
No extracted figures yet
Paper:30610225
No extracted figures yet
Paper:30679038
No extracted figures yet
Paper:30681394
No extracted figures yet

📓 Linked Notebooks (4)

📓 What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesis through the gut-brain axis? - Rich Analysis
Rich notebook with gene expression, pathway enrichment, and statistical analysis
📓 What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesis through the gut-brain axis? — Analysis Notebook
Jupyter notebook for analysis SDA-2026-04-01-gap-20260401-225149: What are the mechanisms underlying what are the mechanisms by which gut microbiome dysbiosis influences parkinson's disease pathogenes …
📓 What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesis through the gut-brain axis? — Rich Analysis
Enhanced notebook with gene expression, pathway enrichment, score heatmaps, and statistical analysis. What are the mechanisms underlying what are the mechanisms by which gut microbiome dysbiosis influ …
📓 Gut Microbiome Dysbiosis and Parkinson's Disease via the Gut-Brain Axis
Real Forge-powered analysis: PubMed search, STRING PPI, Reactome pathways, gene annotations for gut-brain axis / Parkinson's disease research.
→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas

Origin

mutate · gen 1
parent: h-e7e1f943
Expanded the scope from CNS-localized inflammasome activation to a gut-brain axis priming cascade, repositioning the intervention at intestinal microbiome remodeling rather than direct NLRP3 inhibitio
→ Browse all arenas & tournaments

Wiki Pages

NLRP3-Coupled Senomorphic Cycling TherapytherapeuticNLRP3 Inflammasome Modulation for Parkinson's DisetherapeuticNLRP3 Inhibitors for NeurodegenerationtherapeuticNLRP3 Inflammasome Inhibitors for NeurodegenerativtherapeuticNLRP3 Inflammasome InhibitorstherapeuticsPYCARD/ASC ProteinproteinNLRP3 ProteinproteinNLRP3 (NLR Family Pyrin Domain Containing 3)proteinIL1B — Interleukin-1 BetaproteinNLRP3 Inhibitors in Parkinson's Disease: Research mechanismNLRP3 Inflammasome Pathway in NeurodegenerationmechanismNLRP3 Inflammasome Pathway in NeurodegenerationmechanismNLRP3 Inflammasome Inhibitors for Parkinson's DisemechanismNLRP3 Inflammasome Pathway in Alzheimer's DiseasemechanismNLRP3 Inflammasome Activation Pathway in Neurodegemechanism

KG Entities (82)

AADCAGEAGERAHRAHR, IL10, TGFB1APPASCAlpha-synuclein aggregation / synaptic vBDNFCASP1CHRNA7CLDN1CLDN1, OCLN, ZO1, MLCKCREB1CSGADDCDNMT1GLP1RGLP1R, BDNFGLP1_receptor

Dependency Graph (1 upstream, 0 downstream)

Depends On
Microbial Inflammasome Priming Preventionrefines (0.5)

Related Hypotheses

Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates Drives Non-Cell-Autonomous Neurodegeneration
Score: 0.599 | neurodegeneration
Microbial Inflammasome Priming Prevention
Score: 0.584 | neurodegeneration
SASP-Mediated Complement Cascade Amplification
Score: 0.703 | neurodegeneration
TREM2-Dependent Microglial Senescence Transition
Score: 0.692 | neurodegeneration
H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective Effector
Score: 0.675 | neurodegeneration

Estimated Development

Estimated Cost
$1M
Timeline
18 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (494 edges)

activates (3)

inflammasome_complex neuroinflammation_pathway
vagal_signaling_pathway neuroprotection
tight_junction_proteins intestinal_barrier

associated with (28)

gut_microbiome SCFA_production
SCFA_production blood_brain_barrier
NLRP3 neurodegeneration
CASP1 neurodegeneration
IL1B neurodegeneration
...and 23 more

causes (2)

neuroinflammation_pathway Parkinsons_disease
protein_aggregation_pathway Parkinsons_disease

co associated with (38)

AGER RAGE
AGER CHRNA7
AGER TLR4
CHRNA7 TLR4
CLDN1, OCLN, ZO1, MLCK SNCA, HSPA1A, DNMT1
...and 33 more

co discussed (329)

ASC PYCARD
NLRP3 TAU
APP NLRP3
NLRP3 STAT3
DNMT1 HSP70
...and 324 more

component of (1)

NLRP3 inflammasome_complex

encodes (2)

GLP1R GLP1_receptor
SNCA alpha_synuclein

generated (5)

SDA-2026-04-01-gap-20260401-225155 h-e7e1f943
SDA-2026-04-01-gap-20260401-225155 h-74777459
SDA-2026-04-01-gap-20260401-225155 h-6c83282d
SDA-2026-04-01-gap-20260401-225155 h-f9c6fa3f
SDA-2026-04-01-gap-20260401-225155 h-7bb47d7a

implicated in (11)

NLRP3, CASP1, IL1B, PYCARD neurodegeneration
GLP1R, BDNF neurodegeneration
CLDN1, OCLN, ZO1, MLCK neurodegeneration
SNCA, HSPA1A, DNMT1 neurodegeneration
TLR4, SNCA neurodegeneration
...and 6 more

interacts with (42)

NLRP3 CASP1
NLRP3 IL1B
NLRP3 PYCARD
CASP1 NLRP3
CASP1 IL1B
...and 37 more

participates in (19)

alpha_synuclein protein_aggregation_pathway
NLRP3 NLRP3 inflammasome activation
CASP1 NLRP3 inflammasome activation
IL1B NLRP3 inflammasome activation
PYCARD NLRP3 inflammasome activation
...and 14 more

regulates (1)

GLP1_receptor vagal_signaling_pathway

targets (13)

h-e7e1f943 NLRP3, CASP1, IL1B, PYCARD
h-ee1df336 GLP1R, BDNF
h-6c83282d CLDN1, OCLN, ZO1, MLCK
h-74777459 SNCA, HSPA1A, DNMT1
h-2e7eb2ea TLR4, SNCA
...and 8 more

Mechanism Pathway for NLRP3, CASP1, IL1B, PYCARD

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    h_e7e1f943["h-e7e1f943"] -->|targets| NLRP3__CASP1__IL1B__PYCAR["NLRP3, CASP1, IL1B, PYCARD"]
    NLRP3__CASP1__IL1B__PYCAR_1["NLRP3, CASP1, IL1B, PYCARD"] -->|associated with| neurodegeneration["neurodegeneration"]
    NLRP3__CASP1__IL1B__PYCAR_2["NLRP3, CASP1, IL1B, PYCARD"] -->|implicated in| neurodegeneration_3["neurodegeneration"]
    CLDN1__OCLN__ZO1__MLCK["CLDN1, OCLN, ZO1, MLCK"] -->|co associated with| NLRP3__CASP1__IL1B__PYCAR_4["NLRP3, CASP1, IL1B, PYCARD"]
    GLP1R__BDNF["GLP1R, BDNF"] -->|co associated with| NLRP3__CASP1__IL1B__PYCAR_5["NLRP3, CASP1, IL1B, PYCARD"]
    AHR__IL10__TGFB1["AHR, IL10, TGFB1"] -->|co associated with| NLRP3__CASP1__IL1B__PYCAR_6["NLRP3, CASP1, IL1B, PYCARD"]
    NLRP3__CASP1__IL1B__PYCAR_7["NLRP3, CASP1, IL1B, PYCARD"] -->|co associated with| SNCA__HSPA1A__DNMT1["SNCA, HSPA1A, DNMT1"]
    NLRP3__CASP1__IL1B__PYCAR_8["NLRP3, CASP1, IL1B, PYCARD"] -->|co associated with| TH__AADC["TH, AADC"]
    NLRP3__CASP1__IL1B__PYCAR_9["NLRP3, CASP1, IL1B, PYCARD"] -->|co associated with| TLR4__SNCA["TLR4, SNCA"]
    style h_e7e1f943 fill:#4fc3f7,stroke:#333,color:#000
    style NLRP3__CASP1__IL1B__PYCAR fill:#ce93d8,stroke:#333,color:#000
    style NLRP3__CASP1__IL1B__PYCAR_1 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style NLRP3__CASP1__IL1B__PYCAR_2 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration_3 fill:#ef5350,stroke:#333,color:#000
    style CLDN1__OCLN__ZO1__MLCK fill:#ce93d8,stroke:#333,color:#000
    style NLRP3__CASP1__IL1B__PYCAR_4 fill:#ce93d8,stroke:#333,color:#000
    style GLP1R__BDNF fill:#ce93d8,stroke:#333,color:#000
    style NLRP3__CASP1__IL1B__PYCAR_5 fill:#ce93d8,stroke:#333,color:#000
    style AHR__IL10__TGFB1 fill:#ce93d8,stroke:#333,color:#000
    style NLRP3__CASP1__IL1B__PYCAR_6 fill:#ce93d8,stroke:#333,color:#000
    style NLRP3__CASP1__IL1B__PYCAR_7 fill:#ce93d8,stroke:#333,color:#000
    style SNCA__HSPA1A__DNMT1 fill:#ce93d8,stroke:#333,color:#000
    style NLRP3__CASP1__IL1B__PYCAR_8 fill:#ce93d8,stroke:#333,color:#000
    style TH__AADC fill:#ce93d8,stroke:#333,color:#000
    style NLRP3__CASP1__IL1B__PYCAR_9 fill:#ce93d8,stroke:#333,color:#000
    style TLR4__SNCA fill:#ce93d8,stroke:#333,color:#000

3D Protein Structure

🧬 NLRP3 — PDB 7PZC Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesis through the gut-brain axis?

neurodegeneration | 2026-04-01 | completed